The Corporate Reputation of Pharma, 2017: The Patient Perspective - Latin America Edition - ResearchAndMarkets.com

The "The Corporate Reputation of Pharma, 2017 - The Patient Perspective - Latin America Edition" report has been added to ResearchAndMarkets.com's offering.

Introducing the results of the 2017 (3rd) edition of The Corporate Reputation of Pharma - from the Perspective of Latin-American Patient Groups. In total, 71 Latin-American patient groups participated in the 2017 survey.

Latin-American patient groups (and the patients they represent), on the whole, take a more positive view of the pharmaceutical industry than patient groups from most other parts of the world. 50% of the Latin-American patient groups respondent to the 2017 survey stated that the industry's overall corporate reputation was Excellent or Good. Though slightly down on the equivalent 2016 figure of 52%, the 2017 figure was higher than that from the full 2017 respondent body of 1,330 patient groups worldwide - 43%.

What Latin-American patient groups said on innovation and patient engagement in R&D:

• More medicines for unmet patients' needs.
• Defining unmet needs by listening to patients.
• Not using the above processes to leverage patient-group support.

Companies Featured

• AbbVie
• AstraZeneca
• Bayer
• Boehringer Ingelheim
• Bristol-Myers Squibb
• Eli Lilly
• GSK
• Janssen
• Merck & Co/MSD
• Novartis
• Pfizer
• Roche (Genentech in the US)
• Sanofi
  

For more information about this report visit https://www.researchandmarkets.com/research/vjc9j5/the_corporate?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20181113005915/en/

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Pharmaceuticals